JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index

Current Issue 2024/2/2

Original Article
Determination of the therapeutic effects of apigenin on chronic myeloid leukemia stem cells; a mechanistic approach

Published: 14 May 2024

https://doi.org/10.51271/JCHOR-0032

Citation: Ünal A, Göktepe Ö, Çetinkaya M, Baran Y. Determination of the therapeutic effects of apigenin on chronic myeloid leukemia stem cells; a mechanistic approach . J Curr Hematol Oncol Res. 2024;2(2):24-27.

Original Article
Retrospective evaluation of indications for therapeutic plasmapheresis procedures applied in our center

Published: 14 May 2024

https://doi.org/10.51271/JCHOR-0033

Citation: Eryıldız Yücel S, Kuku İ, Kaya E, Erkurt MA, Berber İ. Retrospective evaluation of indications for therapeutic plasmapheresis procedures applied in our center. J Curr Hematol Oncol Res. 2024;2(2):28-32.

Original Article
Evaluation of the relationship between immunohistochemical markers and the prognosis of patients with hepatocellular carcinoma

Published: 14 May 2024

https://doi.org/10.51271/JCHOR-0034

Citation: Kuzucular E, Doran F. Evaluation of the relationship between immunohistochemical markers and the prognosis of patients with hepatocellular carcinoma. J Curr Hematol Oncol Res. 2024;2(2):33-40.

Original Article
Does early granulocyte colony-stimulating factor administration in autologous peripheral blood stem cell transplantation shorten the duration of hospitalization in patients with multiple myeloma?

Published: 14 May 2024

https://doi.org/10.51271/JCHOR-0035

Citation: Keklik M, Topal L, Çelik S, Kaynar L. Does early granulocyte colony-stimulating factor administration in autologous peripheral blood stem cell transplantation shorten the duration of hospitalization in patients with multiple myeloma?.J Curr Hematol Oncol Res. 2024;2(2):41-46.

Review
Superior vena cava syndrome

Published: 14 May 2024

https://doi.org/10.51271/JCHOR-0036

Citation: Hacıömeroğlu A, Yalçın S. Superior vena cava syndrome. J Curr Hematol Oncol Res. 2024;2(2): 47-50.

Case Report
A rare blood transfusion complication: Bacillus thermoamylovorans bacteremia and diffuse pustular rash

Published: 14 May 2024

https://doi.org/10.51271/JCHOR-0037

Citation: Çayıröz K, Tokatlı M, Narlı P, et al. A rare blood transfusion complication: Bacillus thermoamylovorans bacteremia and diffuse pustular rash. J Curr Hematol Oncol Res. 2024; 2(2):51-53.

Most Read Articles

Original Article
ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status

Published: 30 Aug 2023

https://doi.org/10.51271/JCHOR-0013

Citation: Barış Iİ, Büyükbayram H. ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status. J Curr Hematol Oncol Res. 2023;1(3):54-58.

Review
Chronic lymphocytic leukemia

Published: 30 Aug 2023

https://doi.org/10.51271/JCHOR-0014

Citation: Fidan K. Chronic lymphocytic leukemia. J Curr Hematol Oncol Res. 2023;1(3):59-67.

Original Article
Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID 19 antibody level in hematological patients

Published: 26 Feb 2023

https://doi.org/10.51271/JCHOR-0001

Citation: Kaya A, Berber İ, Kuku İ, et al. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID-19 antibody level in hematological patients. J Curr Hematol Oncol Res. 2023; 1(1): 1-4

_Footer